FDA Class II · Drug · August 26, 2026
Libtayo (cemiplimab-rwlc) Injection recall — Regeneron Pharmaceuticals Inc
Lack of Assurance of Sterility
Official ID D-0767-2026 · Official record ↗
Regeneron Pharmaceuticals recalls
Recall found. Regeneron Pharmaceuticals is named in FDA Class II recall D-0767-2026 covering Libtayo (cemiplimab-rwlc) Injection. Hazard: Lack of Assurance of Sterility Identifying details: Lot: 8494000002, Exp 7/31/28. Status: Ongoing.
Models with recalls
All Regeneron Pharmaceuticals recalls
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked October 22, 2026 at 12:00 PM UTC.